Emerging research suggest this peptide, a dual agonist targeting both the gut-brain axis and another hormone, could provide a promising advancement for obesity management . Initial patient trials have https://bookmarkcolumn.com/story21218939/a-retatrutide-peptide-compound-the-advancement-in-weight-management